CG
COLL icon

Caprock Group’s Collegium Pharmaceutical COLL Stock Holding History

Caprock Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
7,018
+135
+2% +$4.61K ﹤0.01% 1088
2026
Q1 		$228K Buy
6,883
+733
+12% +$31K 0.01% 1011
2025
Q4 		$285K Buy
+6,150
New +$257K 0.01% 1016
2025
Q1 		$229K Sell
7,660
-1,038
-12% -$31.7K 0.01% 960
2024
Q4 		$249K Buy
8,698
+543
+7% +$18K 0.01% 864
2024
Q3 		$315K Buy
+8,155
New +$291K 0.01% 712

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Caprock Group's COLL Position: Q2 2026 in Review

Caprock Group increased its Collegium Pharmaceutical (COLL) stake by 2% in Q2 2026, buying an estimated $4.61K and bringing the position to 7,018 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Caprock Group first reported a position in COLL in Q3 2024 and has held it in 6 quarters since. The position peaked at $315K in Q3 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Caprock Group held 7,018 shares of Collegium Pharmaceutical worth $254K as of Q2 2026.
  • Caprock Group bought 135 Collegium Pharmaceutical shares in Q2 2026, an estimated $4.61K.
  • Collegium Pharmaceutical made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1088 holding.
  • Caprock Group first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 6 quarters since.
  • Caprock Group's Collegium Pharmaceutical position peaked at $315K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.